ORI
BIIB icon

Oak Ridge Investments’s Biogen BIIB Stock Holding History

Oak Ridge Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21,180
Closed -$6.75M – 161
2017
Q4 		$6.75M Sell
21,180
-892
-4% -$286K 0.32% 97
2017
Q3 		$6.91M Sell
22,072
-2,406
-10% -$712K 0.28% 100
2017
Q2 		$6.64M Buy
24,478
+1,060
+5% +$280K 0.21% 104
2017
Q1 		$6.4M Buy
23,418
+3,569
+18% +$1.01M 0.22% 97
2016
Q4 		$5.63M Sell
19,849
-7,976
-29% -$2.36M 0.18% 95
2016
Q3 		$8.71M Sell
27,825
-292
-1% -$86.5K 0.23% 93
2016
Q2 		$6.8M Sell
28,117
-995
-3% -$262K 0.17% 100
2016
Q1 		$7.58M Buy
29,112
+840
+3% +$222K 0.19% 97
2015
Q4 		$8.66M Sell
28,272
-538
-2% -$155K 0.21% 98
2015
Q3 		$8.41M Buy
+28,810
New +$9.51M 0.2% 100

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Oak Ridge Investments's BIIB Position: Q1 2018 in Review

Oak Ridge Investments sold out of Biogen (BIIB) in Q1 2018, closing a stake of 21,180 shares — an estimated $6.75M sold.

Oak Ridge Investments first reported a position in BIIB in Q3 2015 and held it in 10 quarters. The position peaked at $8.71M in Q3 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Oak Ridge Investments reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Oak Ridge Investments sold 21,180 Biogen shares in Q1 2018, an estimated $6.75M.
  • Oak Ridge Investments first reported a position in Biogen in Q3 2015 and held it in 10 quarters.
  • Oak Ridge Investments's Biogen position peaked at $8.71M in Q3 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Oak Ridge Investments's 13F filing for Q1 2018, filed 14 May 2018.